ESR1 and breast neoplasm: It has been proposed that hsa-miR-10b confers drug resistance to tamoxifen in ER-driven breast tumors by inducing the EMT process and the growth and proliferation of cancer stem cells (CSCs) in vitro and in vivo [86].